查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403474

2030 年臨床試驗物流市場預測：按階段、服務類型、治療領域、應用、最終用戶和地區進行的全球分析

Clinical Trial Supply & Logistics Market Forecasts to 2030 - Global Analysis By Phase, By Service Type, By Therapeutic Area, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球臨床試驗供應物流市場規模為 39 億美元，預計在預測期內將以 9.5% 的複合年成長率成長，並在 2030 年達到 73 億美元。

臨床試驗物流(CTSL) 是一個專業領域，可確保臨床研究所需的藥物、設備和其他關鍵材料的高效和安全運輸。業務包括庫存管理、包裝、運輸、清關和溫度控制，以確保及時交付到世界各地的臨床試驗地點。 CTSL 促進臨床試驗並促進新藥和治療方法的開發。

臨床試驗需求增加

需求的增加導致臨床試驗供應物流（CTSL）市場的蓬勃發展。隨著越來越多的臨床試驗進行，安全運輸、準確的庫存管理以及對溫度敏感藥物等材料的專業處理至關重要。 CTSL 提供者正在加緊努力，透過投資技術、擴大其全球足跡以及為個人化醫療和病人參與提供客製化解決方案來滿足這一需求。因此，臨床試驗的蓬勃發展直接推動了CTSL市場的成長和創新。

溫度敏感產品

臨床試驗通常涉及對溫度敏感的藥物、疫苗和生物樣本的運輸和儲存，這些樣本需要特定的受控條件來保持功效和完整性。挑戰在於確保這些產品從製造到最終交付的整個供應鏈始終保持在建議的溫度範圍內。偏離指定溫度條件會影響臨床試驗結果的品質和可靠性，並可能導致安全問題和資料不準確。

個人化醫療的興起

隨著治療越來越針對個別患者的情況，對專業和定製藥物的需求不斷增加。這種範式轉移需要靈活高效的供應鏈來滿足從獨特配方到特定患者群體的不同臨床實驗要求。能夠巧妙地調整其供應鏈和物流策略以適應個人化醫療的複雜性的公司可以利用這種不斷變化的形勢，促進創新並提高臨床試驗的成功率。

公眾監督與關注

圍繞臨床試驗的負面看法和爭議可能會損害公眾的信任。道德問題、病人安全或對公司利潤的看法等問題可能會引起媒體、監管機構和公眾的密切關注。在社群媒體和計劃團體的推動下，公眾意識的提高可以放大供應和物流流程中感知到的缺陷的影響。負面看法可能導致監管力度加大、臨床實驗日程延誤以及製藥公司和研究機構的聲譽受損，從而危及臨床試驗的整體成功並阻礙醫學研究的進展。

COVID-19 的影響：

COVID-19 的疫情對市場產生了重大影響，帶來了供應鏈中斷、患者入組延遲以及某些治療領域需求增加等挑戰。封鎖、旅行限制和資源重新分配影響了臨床實驗藥物的及時分配，並導致後勤複雜性增加。製藥公司和委外研發機構必須快速適應，實施彈性供應鏈策略和創新，以確保在這個前所未有的時期臨床試驗的連續性和效率，物流解決方案的重要性凸顯。

第三階段預計將是預測期內最大的部分

第三階段預計將佔據最大佔有率。臨床試驗市場的第三階段是藥物、治療和療法等醫療干預措施開發和評估的關鍵階段。 III 期臨床試驗非常複雜，需要強大的技術和可靠的臨床資源來有效地招募患者、快速推出試驗地點並經濟有效地管理試驗。它被視為臨床試驗。此外，在第三階段臨床試驗中，研究人員仔細收集資料以確認和擴展早期階段。目的是證明具有統計意義的結果，並將介入措施與標準護理、安慰劑或其他相關比較物進行比較。

預計製藥業在預測期內複合年成長率最高

預計製藥業在預測期內將以最有效的速度成長。該專業專注於將臨床實驗藥物及時可靠地運送到各個臨床試驗地點。高效率的供應鏈物流、溫控儲存和法規遵循是重要的方面。在該市場營運的公司提供全面的解決方案，以簡化臨床試驗藥物的複雜供應流程，以支持新藥和治療方法的開發。

比最大的地區

在估計期間，北美佔據了最大的市場佔有率。在北美，由於多種因素，包括感染疾病和慢性病患病率的上升、對個體化治療的需求以及蓬勃發展的製藥業的存在，該市場正在擴大。該地區的法規環境也很有利，FDA 在核准和監督臨床試驗方面發揮關鍵作用。隨著疫苗和治療研究的不斷增加，COVID-19大流行也推動了北美臨床試驗市場的成長。

複合年成長率最高的地區：

由於患者人數的增加和負擔得起的治療，預計亞太地區在預測期內將出現有益的成長。亞太臨床試驗市場具有良好的市場開拓潛力。這是由於該地區負擔得起的臨床試驗、生產設施的擴張、支持性的政府法規以及製藥業務的擴張。較低的成本、更大的治療人群、保留臨床試驗參與者以及監管程序的持續改進是該地區臨床試驗活動增加的主要驅動力。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球臨床試驗供應物流市場：依階段

  • 第一階段
  • 第二階段
  • 第三階段
  • 第四階段

第6章全球臨床試驗供應物流市場：依服務類型

  • 物流/配送
  • 儲存/保留
  • 包裝、標籤、蒙眼
  • 比較器採購
  • 其他服務類型

第7章全球臨床試驗供應物流市場：依治療領域

  • 腫瘤學
  • 神經病學
  • 免疫學
  • 遺傳疾病
  • 感染疾病
  • 代謝紊亂
  • 心臟病學
  • 其他治療領域

第8章全球臨床試驗供應物流市場：依應用分類

  • 低分子
  • 疫苗
  • 單株抗體
  • 細胞和基因治療
  • 其他用途

第9章全球臨床試驗供應物流市場：依最終使用者分類

  • 藥品
  • 生物製藥
  • 醫療設備
  • 其他最終用戶

第10章全球臨床試驗供應物流市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東/非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東/非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Parexel
  • Thermo Fisher Scientific（Patheon）
  • Catalent, Inc.
  • Packaging Coordinators Inc.
  • Almac Group
  • Piramal Pharma Solutions
  • UDG Healthcare
  • DHL
  • FedEx
  • Movianto
Product Code: SMRC24699

According to Stratistics MRC, the Global Clinical Trial Supply & Logistics Market is accounted for $3.9 billion in 2023 and is expected to reach $7.3 billion by 2030 growing at a CAGR of 9.5% during the forecast period. Clinical Trial Supply & Logistics (CTSL) is a specialized field ensuring the efficient and secure movement of medication, equipment, and other vital materials needed for clinical research. It encompasses activities like inventory management, packaging, transportation, customs clearance, and temperature control, ensuring timely delivery to clinical trial sites across the globe. CTSL ensures clinical trials run smoothly, contributing to the development of new drugs and therapies.

Market Dynamics:

Driver:

Increased demand for clinical trials

The increased demand translates to a booming Clinical Trial Supply & Logistics (CTSL) market. As more trials are conducted, the need for secure transport, precise inventory management, and specialized handling of materials like temperature-sensitive drugs becomes crucial. CTSL providers are stepping up to meet this demand by investing in technology, expanding global reach, and offering customized solutions for personalized medicine and patient engagement. Thus, the booming clinical trial landscape directly fuels the growth and innovation within the CTSL market.

Restraint:

Temperature sensitive products

Clinical trials often involve the transportation and storage of temperature-sensitive drugs, vaccines, or biological samples that require specific and controlled conditions to maintain their efficacy and integrity. The challenge lies in ensuring that these products are consistently maintained within the recommended temperature ranges throughout the supply chain, from manufacturing to final delivery. Any deviation from the specified temperature conditions can compromise the quality and reliability of the clinical trial results, leading to potential safety issues and data inaccuracies.

Opportunity:

The rise of personalized medicine

As treatments increasingly target individual patient profiles, the demand for specialized and customized pharmaceuticals escalates. This paradigm shift necessitates a flexible and efficient supply chain to accommodate diverse trial requirements, ranging from unique drug formulations to specific patient populations. Companies that adeptly adapt their supply and logistics strategies to the intricacies of personalized medicine stand to capitalize on this evolving landscape, driving innovation and enhancing clinical trial success.

Threat:

Public scrutiny and concerns

Any negative perception or controversy surrounding these trials can undermine public trust. Issues such as ethical concerns, patient safety, or perceived corporate interests may trigger intense scrutiny from the media, regulatory bodies, and the general public. Heightened public awareness, fueled by social media and advocacy groups, can amplify the impact of any perceived shortcomings in the supply and logistics processes. Negative perceptions can result in increased regulatory scrutiny, delays in trial timelines, and reputational damage for pharmaceutical companies and research organizations, thereby jeopardizing the overall success of clinical trials and hindering advancements in medical research.

COVID-19 Impact:

The COVID-19 pandemic has significantly impacted the market, introducing challenges such as disrupted supply chains, delays in patient enrollment, and increased demand for certain therapeutic areas. Lockdowns, travel restrictions, and resource reallocation have affected the timely distribution of investigational products, leading to logistical complexities. Pharmaceutical companies and contract research organizations have had to adapt rapidly, emphasizing the importance of resilient supply chain strategies and innovative logistics solutions to ensure the continuity and efficiency of clinical trials during these unprecedented times.

The Phase III segment is expected to be the largest during the forecast period

The Phase III segment is estimated to hold the largest share. The Phase 3 segment of the clinical trials market represents a crucial stage in the development and evaluation of medical interventions, such as drugs, treatments, or therapies. Phase III clinical trials are considered complex clinical trials that require both robust technologies and reliable clinical resources to recruit patients efficiently, initiate sites quickly, and provide cost-effective study management. Furthermore, during Phase 3 trials, researchers carefully gather data to confirm and extend the findings from earlier phases. They aim to demonstrate statistically significant results and compare the intervention against standard treatments, placebos, or other relevant comparators.

The pharmaceuticals segment is expected to have the highest CAGR during the forecast period

During the anticipated period, the pharmaceuticals segment is expected to increase at the most effective rate. This specialized sector focuses on ensuring the timely and secure delivery of investigational drugs to various clinical trial sites. Efficient supply chain logistics, temperature-controlled storage, and regulatory compliance are critical aspects. Companies operating in this market provide comprehensive solutions to streamline the complex process of supplying pharmaceuticals for clinical trials, supporting the development of new drugs and therapies.

Region with largest share:

North America commanded the largest market share during the extrapolated period. The market is expanding in North America due to a number of factors, including the rising incidence of infectious and chronic diseases, the demand for personalised treatment, and the existence of a thriving pharmaceutical sector. The regulatory climate in the area is also supportive, with the FDA playing a key role in the approval and supervision of clinical trials. With an increase in vaccine and therapy studies, the COVID-19 pandemic has also fuelled growth in the North American clinical trials market.

Region with highest CAGR:

Asia-Pacific region is expected to witness profitable growth over the projection period, due to the growing patient base and affordable treatments. The clinical trials market has excellent development potential in Asia and the Pacific. This can be attributed to the region's affordable clinical trials, expanding manufacturing facilities, enacting supportive government regulations, and expanding pharmaceutical business. Cost savings, a large treatment population, participant retention in clinical trials, and ongoing regulatory procedural improvements are mostly responsible for the rise of clinical trial activities in the area.

Key players in the market:

Some of the key players in Clinical Trial Supply & Logistics market include Parexel, Thermo Fisher Scientific (Patheon), Catalent, Inc., Packaging Coordinators Inc., Almac Group, Piramal Pharma Solutions, UDG Healthcare, DHL, FedEx and Movianto.

Key Developments:

In October 2023, Piramal Pharma Solutions partnered with an AI-powered platform provider to streamline clinical trial supply chain management. This partnership leverages AI and machine learning to optimize inventory management, route planning, and real-time visibility into the location and status of clinical trial supplies.

In September 2023, Thermo Fisher Scientific (Patheon) acquired a leading European clinical trial logistics company, significantly increasing presence in Europe and expertise in complex trial logistics.

In February 2023, Parexel launched a new expert series, New Medicines, Novel Insights. The series features fresh insights from the company's global, cross-functional experts analyzing drug development trends and offering evidence-based guidance to the biopharmaceutical industry.

Phases Covered:

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Service Types Covered:

  • Logistics & Distribution
  • Storage & Retention
  • Packaging, Labeling, and Blinding
  • Comparator Sourcing
  • Other Service Types

Therapeutic Areas Covered:

  • Oncology
  • Neurology
  • Immunology
  • Genetic Diseases
  • Infectious Diseases
  • Metabolic Disorders
  • Cardiology
  • Other Therapeutic Areas

Applications Covered:

  • Small Molecules
  • Vaccine
  • Monoclonal Antibodies
  • Cell & Gene Therapy
  • Other Applications

End User Covered:

  • Pharmaceuticals
  • Biologicals
  • Medical Device
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Clinical Trial Supply & Logistics Market, By Phase

  • 5.1 Introduction
  • 5.2 Phase I
  • 5.3 Phase II
  • 5.4 Phase III
  • 5.5 Phase IV

6 Global Clinical Trial Supply & Logistics Market, By Service Type

  • 6.1 Introduction
  • 6.2 Logistics & Distribution
  • 6.3 Storage & Retention
  • 6.4 Packaging, Labeling, and Blinding
  • 6.5 Comparator Sourcing
  • 6.6 Other Service Types

7 Global Clinical Trial Supply & Logistics Market, By Therapeutic Area

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Neurology
  • 7.4 Immunology
  • 7.5 Genetic Diseases
  • 7.6 Infectious Diseases
  • 7.7 Metabolic Disorders
  • 7.8 Cardiology
  • 7.9 Other Therapeutic Areas

8 Global Clinical Trial Supply & Logistics Market, By Application

  • 8.1 Introduction
  • 8.2 Small Molecules
  • 8.3 Vaccine
  • 8.4 Monoclonal Antibodies
  • 8.5 Cell & Gene Therapy
  • 8.6 Other Applications

9 Global Clinical Trial Supply & Logistics Market, By End User

  • 9.1 Introduction
  • 9.2 Pharmaceuticals
  • 9.3 Biologicals
  • 9.4 Medical Device
  • 9.5 Other End Users

10 Global Clinical Trial Supply & Logistics Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Parexel
  • 12.2 Thermo Fisher Scientific (Patheon)
  • 12.3 Catalent, Inc.
  • 12.4 Packaging Coordinators Inc.
  • 12.5 Almac Group
  • 12.6 Piramal Pharma Solutions
  • 12.7 UDG Healthcare
  • 12.8 DHL
  • 12.9 FedEx
  • 12.10 Movianto

List of Tables

  • Table 1 Global Clinical Trial Supply & Logistics Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Clinical Trial Supply & Logistics Market Outlook, By Phase (2021-2030) ($MN)
  • Table 3 Global Clinical Trial Supply & Logistics Market Outlook, By Phase I (2021-2030) ($MN)
  • Table 4 Global Clinical Trial Supply & Logistics Market Outlook, By Phase II (2021-2030) ($MN)
  • Table 5 Global Clinical Trial Supply & Logistics Market Outlook, By Phase III (2021-2030) ($MN)
  • Table 6 Global Clinical Trial Supply & Logistics Market Outlook, By Phase IV (2021-2030) ($MN)
  • Table 7 Global Clinical Trial Supply & Logistics Market Outlook, By Service Type (2021-2030) ($MN)
  • Table 8 Global Clinical Trial Supply & Logistics Market Outlook, By Logistics & Distribution (2021-2030) ($MN)
  • Table 9 Global Clinical Trial Supply & Logistics Market Outlook, By Storage & Retention (2021-2030) ($MN)
  • Table 10 Global Clinical Trial Supply & Logistics Market Outlook, By Packaging, Labeling, and Blinding (2021-2030) ($MN)
  • Table 11 Global Clinical Trial Supply & Logistics Market Outlook, By Comparator Sourcing (2021-2030) ($MN)
  • Table 12 Global Clinical Trial Supply & Logistics Market Outlook, By Other Service Types (2021-2030) ($MN)
  • Table 13 Global Clinical Trial Supply & Logistics Market Outlook, By Therapeutic Area (2021-2030) ($MN)
  • Table 14 Global Clinical Trial Supply & Logistics Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 15 Global Clinical Trial Supply & Logistics Market Outlook, By Neurology (2021-2030) ($MN)
  • Table 16 Global Clinical Trial Supply & Logistics Market Outlook, By Immunology (2021-2030) ($MN)
  • Table 17 Global Clinical Trial Supply & Logistics Market Outlook, By Genetic Diseases (2021-2030) ($MN)
  • Table 18 Global Clinical Trial Supply & Logistics Market Outlook, By Infectious Diseases (2021-2030) ($MN)
  • Table 19 Global Clinical Trial Supply & Logistics Market Outlook, By Metabolic Disorders (2021-2030) ($MN)
  • Table 20 Global Clinical Trial Supply & Logistics Market Outlook, By Cardiology (2021-2030) ($MN)
  • Table 21 Global Clinical Trial Supply & Logistics Market Outlook, By Other Therapeutic Areas (2021-2030) ($MN)
  • Table 22 Global Clinical Trial Supply & Logistics Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 Global Clinical Trial Supply & Logistics Market Outlook, By Small Molecules (2021-2030) ($MN)
  • Table 24 Global Clinical Trial Supply & Logistics Market Outlook, By Vaccine (2021-2030) ($MN)
  • Table 25 Global Clinical Trial Supply & Logistics Market Outlook, By Monoclonal Antibodies (2021-2030) ($MN)
  • Table 26 Global Clinical Trial Supply & Logistics Market Outlook, By Cell & Gene Therapy (2021-2030) ($MN)
  • Table 27 Global Clinical Trial Supply & Logistics Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 28 Global Clinical Trial Supply & Logistics Market Outlook, By End User (2021-2030) ($MN)
  • Table 29 Global Clinical Trial Supply & Logistics Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 30 Global Clinical Trial Supply & Logistics Market Outlook, By Biologicals (2021-2030) ($MN)
  • Table 31 Global Clinical Trial Supply & Logistics Market Outlook, By Medical Device (2021-2030) ($MN)
  • Table 32 Global Clinical Trial Supply & Logistics Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.